Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002106190 | SCV002434007 | likely benign | not provided | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500165 | SCV002807787 | likely benign | Donnai-Barrow syndrome | 2021-12-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003053433 | SCV003551588 | likely benign | Inborn genetic diseases | 2021-08-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |